The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease.
about
Autoimmune blistering diseases in females: a review.Quality of life, depression, anxiety and loneliness in patients with bullous pemphigoid. A case control studyOutcome measures for autoimmune blistering diseases.Pemphigus vulgaris: an evidence-based treatment update.Valuation of pemphigus vulgaris and pemphigus foliaceus health states: a convenience sample experiment.Loss of Work Productivity and Quality of Life in Patients With Autoimmune Bullous Dermatoses.Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.Burden of disease during quiescent periods in patients with pemphigus.The three dimensions of skin disease burden: 'now', 'long term' and 'family'.Psychosocial impact of inherited and autoimmune blistering diseases.Pemphigus
P2860
Q33640302-B5FFFB03-2838-4C23-BDF6-BD59F1BC6AE2Q37380230-3A2B565F-96C8-48A5-AD6D-AA982BCE9B2EQ38307352-D55B3FE2-0E8A-4F7F-A6BF-788FBDC37601Q38345404-BB65ADFB-F7BE-40EC-8E8A-E206A447AFCEQ38803453-EB701CA4-35E6-4505-A4A6-18B89869D501Q47569970-27A36416-7581-4678-9731-AF7737F9495FQ47988514-D3F9A7A2-9E5C-4AE2-BE51-15683B4805EEQ48096667-6C51B13C-BCC7-4893-BC1B-8AE2EC5D06A4Q48142648-CCB32910-348D-4795-94CD-D2CEA17AFCEEQ54935935-B8D92B88-73BD-40C5-A0F7-014CF1629C9FQ56603745-0CD4664C-FBAB-412E-A117-8D2E3C584996
P2860
The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The development and validation ...... autoimmune blistering disease.
@ast
The development and validation ...... autoimmune blistering disease.
@en
type
label
The development and validation ...... autoimmune blistering disease.
@ast
The development and validation ...... autoimmune blistering disease.
@en
prefLabel
The development and validation ...... autoimmune blistering disease.
@ast
The development and validation ...... autoimmune blistering disease.
@en
P2093
P2860
P50
P356
P1476
The development and validation ...... autoimmune blistering disease
@en
P2093
A Dermawan
A Tjokrowidjaja
B S Daniel
D F Murrell
L M Rhodes
S S Venugopal
P2860
P304
P356
10.1111/BJD.12623
P407
P577
2013-11-01T00:00:00Z